title: The Nobel Prize laureate - father of anaphylaxis Charles-Robert Richet (1850-1935) and his anticancerous serum.
abstract: Professor of physiology Charles-Robert Richet, winner of the Nobel Prize in 1913, is best known for his work on anaphylaxis. However, with his collaborator Jules Héricourt studied the effects of antibody treatment and made the very first attempts to fight cancer with serotherapy. Being versatile, Richet contributed in neurology, psychology and was also a poet, playwrighter, pacifist and pioneer in aviation.
authors.affiliation: Department of History of Medicine, Medical School, University of Athens, Greece. lyon48@otenet.gr
authors.forename: G
authors.initials: G
authors.lastname: Androutsos
authors.forename: M
authors.initials: M
authors.lastname: Karamanou
authors.forename: E
authors.initials: E
authors.lastname: Stamboulis
authors.forename: I
authors.initials: I
authors.lastname: Liappas
authors.forename: E
authors.initials: E
authors.lastname: Lykouras
authors.forename: G N
authors.initials: GN
authors.lastname: Papadimitriou
mesh_terms: D000486:Allergy and Immunology / Q000266:history*; D000707:Anaphylaxis / Q000276:immunology; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive / Q000266:history*; D008495:Medical Oncology / Q000266:history*; D009369:Neoplasms / Q000628:therapy*; D009613:Nobel Prize
chemical_list: D007106:Immune Sera